Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades Unity Software to Neutral

BTIG Downgrades Unity Software to Neutral

BTIG analyst Clark Lampen downgrades Unity Software (NYSE:U) from Buy to Neutral.

byBenzinga Newsdesk

December 8, 2022

1 minute read

BTIG analyst Clark Lampen downgrades Unity Software (NYSE:U) from Buy to Neutral.

Ripple CEO Says Legal Expenses Surge To $200M, Blames SEC For Bullying

By Murtuza Merchant

September 21, 3:04 PM

Ripple (CRYPTO: XRP) CEO Brad Garlinghouse revealed the company's legal expenses surged to a staggering $200 million, doubling from th

$XRP

Tharimmune Announces Dosing Of First Patient In Phase 1 Clinical Trial Of TH104, Its Lead Candidate For Pruritus In Primary Biliary Cholangitis

By Benzinga Newsdesk

February 5, 9:35 AM

Phase 1 clinical trial dosing of first patient complete; primary objective to assess safety/tolerability and absolute bioavailability of TH104Phase 1 study expected to be completed in 1Q24 with topline readout in

THAR

Goldman Sachs Upgrades Aluminum Corp of China to Neutral

By Benzinga Newsdesk

August 25, 1:56 PM

Goldman Sachs analyst Trina Chen upgrades Aluminum Corp of China (NYSE:ACH) from Sell to Neutral.

ACH

Interactive Brokers Group Q4 EPS $1.30 Beats $1.17 Estimate, Sales $958.00M Beat $913.75M Estimate

By Benzinga Newsdesk

January 17, 5:02 PM

Interactive Brokers Group (NASDAQ:IBKR) reported quarterly earnings of $1.30 per share which beat the analyst consensus estimate of $1.17 by 11.11 percent. This is a 56.63 percent increase over earnings of $0.83 per

IBKR

BTIG Downgrades Unity Software to Neutral

Related Posts

Ripple CEO Says Legal Expenses Surge To $200M, Blames SEC For Bullying

Tharimmune Announces Dosing Of First Patient In Phase 1 Clinical Trial Of TH104, Its Lead Candidate For Pruritus In Primary Biliary Cholangitis

Goldman Sachs Upgrades Aluminum Corp of China to Neutral

Interactive Brokers Group Q4 EPS $1.30 Beats $1.17 Estimate, Sales $958.00M Beat $913.75M Estimate